Exocrine Pancreatic Insufficiency: A Review

Authors

  • Ashish Rao M Research Scholar, Department of Internal Medicine, Kasturba Medical College, Manipal University, Karnataka, India
  • Kusalik Boppana
  • Nivedita .

DOI:

https://doi.org/10.37591/rrjomst.v12i2.3228

Keywords:

Malnutrition, diagnosis, treatment, chronic pancreatitis, pancreatic cancer, exocrine pancreatic insufficiency

Abstract

“Exocrine pancreatic insufficiency”, often known as EPI, is a condition diagnosed in gastroenterology that is defined by insufficient or inaccurate pancreatic fluid secretion as well as pancreatic lipase function. The clinical symptoms as well as metabolic variations that EPI might cause can sometimes lead to outcomes that put a person's life in jeopardy. EPI is common in a variety of conditions that are not related to the pancreas, in addition to those that involve the pancreas, when and it should be recognized and promptly treated. However, there are a variety of tests offered, and the most common ones for diagnosing EPI are indirect, non-invasive procedures such as monitoring the level of faecal elastase (FE). This review paper will cover the latest research on the prevalence, diagnostic methods, and treatment of EPI, emphasizing the central role of 'pancreatic enzyme replacement therapy (PERT)' in its management.

References

Whitcomb, D. C., Lehman, G. A., Vasileva, G., Malecka-Panas, E., Gubergrits, N., Shen, Y., ... & Caras, S. (2010). Pancrelipase delayed-release capsules (CREON) for exocrine pancreatic insufficiency due to chronic pancreatitis or pancreatic surgery: A double-blind randomized trial. Official journal of the American College of Gastroenterology| ACG, 105(10), 2276-2286.

Pezzilli, R., Labate, A. M., Ceciliato, R., Frulloni, L., Cavestro, G. M., Comparato, G., ... & Gullo, L. (2005). Quality of life in patients with chronic pancreatitis. Digestive and liver disease, 37(3), 181-189.

Borowitz, D., Konstan, M. W., O'Rourke, A., Cohen, M., Hendeles, L., & Murray, F. T. (2007). Coefficients of fat and nitrogen absorption in healthy subjects and individuals with cystic fibrosis. The Journal of Pediatric Pharmacology and Therapeutics, 12(1), 47-52.

Chowdhury, R. S., & Forsmark, C. E. (2003). Pancreatic function testing. Alimentary pharmacology & therapeutics, 17(6), 733-750.

Domínguez-Muñoz, J. E., Nieto, L., Vilariño, M., Lourido, M. V., & Iglesias-García, J. (2016). Development and diagnostic accuracy of a breath test for pancreatic exocrine insufficiency in chronic pancreatitis. Pancreas, 45(2), 241-247.

Löhr, J. M., Dominguez-Munoz, E., Rosendahl, J., Besselink, M., Mayerle, J., Lerch, M. M., ... & HaPanEU/UEG Working Group. (2017). United European Gastroenterology evidence-based guidelines for the diagnosis and therapy of chronic pancreatitis (HaPanEU). United European gastroenterology journal, 5(2), 153-199.

González-Sánchez, V., Amrani, R., González, V., Trigo, C., Picó, A., & de-Madaria, E. (2017). Diagnosis of exocrine pancreatic insufficiency in chronic pancreatitis: 13C-Mixed Triglyceride Breath Test versus Fecal Elastase. Pancreatology, 17(4), 580-585.

Struyvenberg, M. R., Martin, C. R., & Freedman, S. D. (2017). Practical guide to exocrine pancreatic insufficiency - Breaking the myths. BMC medicine, 15(1), 29.

Vanga, R. R., Tansel, A., Sidiq, S., El-Serag, H. B., & Othman, M. O. (2018). Diagnostic Performance of Measurement of Fecal Elastase-1 in Detection of Exocrine Pancreatic Insufficiency: Systematic Review and Meta-analysis. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 16(8), 1220–1228.e4.

Weiss, F. U., Budde, C., & Lerch, M. M. (2016). Specificity of a polyclonal fecal elastase ELISA for CELA3. PLoS One, 11(7), e0159363.

Vanga, R. R., Tansel, A., Sidiq, S., El-Serag, H. B., & Othman, M. O. (2018). Diagnostic performance of measurement of fecal elastase-1 in detection of exocrine pancreatic insufficiency: systematic review and meta-analysis. Clinical Gastroenterology and Hepatology, 16(8), 1220-1228.

Singh, V. K., Haupt, M. E., Geller, D. E., Hall, J. A., & Diez, P. M. Q. (2017). Less common etiologies of exocrine pancreatic insufficiency. World Journal of Gastroenterology, 23(39), 7059.

Söderström, L., Rosenblad, A., Adolfsson, E. T., & Bergkvist, L. (2017). Malnutrition is associated with increased mortality in older adults regardless of the cause of death. British Journal of Nutrition, 117(4), 532-540.

Raphael, K. L., Chawla, S., Kim, S., Keith, C. G., Propp, D. R., Chen, Z. N., ... & Willingham, F. F. (2017). Pancreatic insufficiency secondary to tobacco exposure: A controlled cross-sectional evaluation. Pancreas, 46(2), 237.

Sand, J., & Nordback, I. (2009). Acute pancreatitis: risk of recurrence and late consequences of the disease. Nature reviews Gastroenterology & hepatology, 6(8), 470-477.

Huang, W., de la Iglesia-Garcia, D., Baston-Rey, I., Calvino-Suarez, C., Larino-Noia, J., Iglesias-Garcia, J., ... & Sutton, R. (2019). Exocrine pancreatic insufficiency following acute pancreatitis: systematic review and meta-analysis. Digestive diseases and sciences, 64(7), 1985-2005.

Tseng, D. S., Molenaar, I. Q., Besselink, M. G., van Eijck, C. H., Rinkes, I. H. B., & van Santvoort, H. C. (2016). Pancreatic exocrine insufficiency in patients with pancreatic or periampullary cancer: a systematic review. Pancreas, 45(3), 325-330.

Struyvenberg, M. R., Martin, C. R., & Freedman, S. D. (2017). Practical guide to exocrine pancreatic insufficiency–breaking the myths. BMC medicine, 15(1), 1-8.

Pham, A., & Forsmark, C. (2018). Chronic pancreatitis: review and update of etiology, risk factors, and management. F1000Research, 7. 20.DiMagno, M. J., & Forsmark, C. E. (2018). Chronic pancreatitis and small intestinal bacterial overgrowth. Pancreatology: official journal of the International Association of Pancreatology (IAP)...[et al.], 18(4), 360-362.

de la Iglesia-Garcia, D., Vallejo-Senra, N., Iglesias-Garcia, J., López-López, A., Nieto, L., & Domínguez-Muñoz, J. E. (2018). Increased risk of mortality associated with pancreatic exocrine insufficiency in patients with chronic pancreatitis. Journal of clinical gastroenterology, 52(8), e63-e72.

Domínguez-Muñoz, J. E., Nieto-Garcia, L., López-Díaz, J., Lariño-Noia, J., Abdulkader, I., & Iglesias-Garcia, J. (2018). Impact of the treatment of pancreatic exocrine insufficiency on survival of patients with unresectable pancreatic cancer: a retrospective analysis. BMC cancer, 18(1), 1-8.

Roberts, K. J., Schrem, H., Hodson, J., Angelico, R., Dasari, B. V., Coldham, C. A., ... & Mirza, D. F. (2017). Pancreas exocrine replacement therapy is associated with increased survival following pancreatoduodenectomy for periampullary malignancy. Hpb, 19(10), 859-867.

Forsmark, C. E., Tang, G., Tuft, M., Xu, H., Hughes, S. J., & Yadav, D. (2017, November). Oral pancreatic enzyme replacement therapy (PERT) in patients with pancreatic cancer (PCa) is infrequent and suboptimal: a national level analysis. In Pancreas (Vol. 46, No. 10, pp. 1400-1400). TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA: LIPPINCOTT WILLIAMS & WILKINS. 25.Forsmark, C., Tang, G., Xu, H., & Yadav, D. (2017). Oral pancreatic enzyme replacement therapy (PERT) in chronic pancreatitis (CP) is infrequent and often suboptimal: A national level analysis. Gastroenterology, 152(5), S677.

Downloads

Published

2023-08-30

Issue

Vol. 12 No. 2 (2023)

Section

Review Article

License

Declaration and Copyright Transfer Form

(to be completed by authors)

I/ We, the undersigned author(s) of the submitted manuscript, hereby declare, that the above manuscript which is submitted for publication in the STM Journals(s), is not published already in part or whole (except in the form of abstract) in any journal or magazine for private or public circulation, and, is not under consideration of publication elsewhere.

  • I/We will not withdraw the manuscript after 1 week of submission as I have read the Author Guidelines and will adhere to the guidelines.
  • I/We Author(s ) have niether given nor will give this manuscript elsewhere for publishing after submitting in STM Journal(s).
  • I/ We have read the original version of the manuscript and am/ are responsible for the thought contents embodied in it. The work dealt in the manuscript is my/ our own, and my/ our individual contribution to this work is significant enough to qualify for authorship.
  •  I/We also agree to the authorship of the article in the following order:

Author’s name                                    

 

1. ________________

2. ________________

3. ________________

4. ________________

 

We  Author(s) tick this box and would request you to consider it as our signature as we agree to the terms of this Copyright Notice, which will apply to this submission if and when it is published by this journal.